AOTI Inc.

Sep 16, 2020

Expansion of Topical Wound Oxygen (TWO2) Product Family Extends Treatment to Chronic Wound Patients with Larger Limbs, Venous and Diabetic Foot Ulcers

Apr 06, 2020

Topical Wound Oxygen (TWO2) Therapy Treats High-Risk Patients Safely at Home During the COVID-19 Pandemic

Jun 19, 2019

AOTI Inc. Awarded New Five-Year Federal Supply Schedule Contract by the Department of Veterans Affairs

Jan 18, 2019

AOTI Enters Into Multi-Million USD Strategic Relationship for Chinese Market

Oct 18, 2018

AOTI to Participate at Jefferies 2018 London Healthcare Conference and Present at the 3rd Annual INVEUR$TIVAL Showcase in Partnership with Jefferies

Oct 11, 2018

TWO2 Randomized Controlled Trial Chosen as One of the Best Abstracts Presented at the Leading Diabetic Foot Global Conference

Aug 08, 2018

Opening of New Manufacturing Facility to Meet Expanding Demand for Topical Wound Oxygen (TWO2) Therapy Devices

May 22, 2018

Unprecedented Study Results Demonstrating Topical Wound Oxygen Effectiveness Presented at Major Wound Care Conferences

May 02, 2018

Leadership Additions to Executive Team to Support Strategic Growth

Aug 15, 2017

AOTI Inc. Announces New York City Office Grand Opening